Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyanamide-associated alcoholic liver disease: a sequential histological evaluation

A Yokoyama1, S Sato, K Maruyama

  • 1National Institute on Alcoholism, Kurihama National Hospital, Kanagawa, Japan.

Alcoholism, Clinical and Experimental Research
|October 1, 1995
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized phase II study of cisplatin, irinotecan and etoposide combinations administered weekly or every 4 weeks for extensive small-cell lung cancer (JCOG9902-DI).

Annals of oncology : official journal of the European Society for Medical Oncology·2003
Same author

T-helper 1 cells induce alveolitis but do not lead to pulmonary fibrosis in mice.

The European respiratory journal·2003
Same author

[Alcohol and oropharyngolaryngeal and digestive tract cancer].

Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence·2002
Same author

A study of the combination of gemcitabine hydrochloride (LY188011) and cisplatin in non-small-cell lung cancer: 3-week schedule.

International journal of clinical oncology·2002
Same author

A phase II study of paclitaxel plus cisplatin for advanced non-small-cell lung cancer in Japanese patients.

Cancer chemotherapy and pharmacology·2002
Same author

Three novel mutations of the RPGR gene exon ORF15 in three Japanese families with X-linked retinitis pigmentosa.

American journal of medical genetics·2001

This study reveals how chronic alcohol use combined with cyanamide treatment impacts liver health. Cyanamide-induced ground-glass inclusions (GGIs) in hepatocytes can proliferate or regress, affecting disease progression in relapsed alcoholics.

Area of Science:

  • Hepatology
  • Toxicology
  • Gastroenterology

Background:

  • Chronic alcohol consumption is a leading cause of liver disease.
  • Cyanamide is an antidipsotropic agent used to deter alcohol relapse.
  • The combined effects of alcohol and cyanamide on liver histopathology are not well understood.

Purpose of the Study:

  • To investigate the histopathological progression of liver disease in alcoholics treated with cyanamide who subsequently relapsed.
  • To identify changes in liver biopsy specimens related to cyanamide exposure and alcohol relapse.

Main Methods:

  • Sequential liver biopsy specimens were analyzed from 29 alcoholics with histories of cyanamide treatment and relapse.
  • Hepatocytes were examined for ground-glass inclusions (GGIs).

Related Experiment Videos

  • Cases were grouped based on the proliferation or regression of GGIs.

    • Main Results:

    • Cyanamide induced GGIs in hepatocytes.
    • Group 1 (14 cases) showed GGI proliferation or increase; Group 2 (15 cases) showed GGI regression or absence.
    • Acidophilic bodies and portal inflammation increased in Group 1, but not in Group 2.
    • Fibrotic changes did not differ significantly between groups.

    Conclusions:

    • The combination of cyanamide and alcohol in relapsed patients can lead to the emergence of GGIs, acidophilic bodies, and portal inflammation.
    • The duration of cyanamide treatment and drug-free periods influence GGI changes.
    • These findings highlight the complex histopathological liver changes associated with cyanamide use in alcohol relapse.